Luanna Yang is a Rheumatology/Immunology physician. OpenAlex indexes 18 publications with 351 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
10 Hagen Dr Ste 20
Rochester, NY 146252663
Telephone
585-922-8350Registry record last updated 6 Dec 2021.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
68.9%Histamine-1 Receptor Antagonist30.3%Azelastine Hcl100%Part D≥49 patientsCorticosteroid14.1%Breyna66%Fluticasone Propionate34%Part D<11 patients+ 6 more classes in this area
Dermatology
16.8%Interleukin-4 Receptor alpha Antagonist14.3%Dupixent Pen52%Dupixent Syringe48%Part D<11 patientsCorticosteroid2.5%Triamcinolone Acetonide100%Part D<11 patientsMetabolism & gastrointestinal
10.2%Corticosteroid7.1%Prednisone100%Part D≥20 patientsProton pump inhibitor3.1%Omeprazole100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Dosing, safety, and quality of life after peanut immunotherapy trials: A long-term follow-up study
Carolina Digital Repository (University of North Carolina at Chapel Hill)
2025 - Five-year follow-up of early intervention peanut oral immunotherapy
Carolina Digital Repository (University of North Carolina at Chapel Hill)
2025 - Patient satisfaction with telemedicine encounters in an allergy and immunology practice during the coronavirus disease 2019 pandemic
Annals of Allergy Asthma & Immunology
2020 - Inpatient Electronic Consultations (E-consults) in Allergy/Immunology
The Journal of Allergy and Clinical Immunology In Practice
2020 - Five-year follow-up of early intervention peanut oral immunotherapy
The Journal of Allergy and Clinical Immunology In Practice
2020
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”